MYQUISTA Trademark

Trademark Overview

On Thursday, August 15, 2019, a trademark application was filed for MYQUISTA with the United States Patent and Trademark Office. The USPTO has given the MYQUISTA trademark a serial number of 88580099. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 13, 2023. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The MYQUISTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment, alleviation and prevention of moderate to severe vasomotor symptoms associated with menopause and women's hormonal disorders
myquista

General Information

Serial Number88580099
Word MarkMYQUISTA
Filing DateThursday, August 15, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment, alleviation and prevention of moderate to severe vasomotor symptoms associated with menopause and women's hormonal disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 30, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054
Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Monday, February 13, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 13, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, February 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 2, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, February 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 26, 2022SOU EXTENSION 5 GRANTED
Thursday, July 7, 2022SOU EXTENSION 5 FILED
Tuesday, July 26, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 7, 2022TEAS EXTENSION RECEIVED
Thursday, July 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 7, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 7, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 3, 2022SOU EXTENSION 4 GRANTED
Monday, January 3, 2022SOU EXTENSION 4 FILED
Monday, January 3, 2022TEAS EXTENSION RECEIVED
Friday, July 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 7, 2021SOU EXTENSION 3 GRANTED
Wednesday, July 7, 2021SOU EXTENSION 3 FILED
Wednesday, July 7, 2021TEAS EXTENSION RECEIVED
Friday, December 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 9, 2020SOU EXTENSION 2 GRANTED
Wednesday, December 9, 2020SOU EXTENSION 2 FILED
Wednesday, December 9, 2020TEAS EXTENSION RECEIVED
Saturday, July 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 2, 2020SOU EXTENSION 1 GRANTED
Thursday, July 2, 2020SOU EXTENSION 1 FILED
Thursday, July 2, 2020TEAS EXTENSION RECEIVED
Tuesday, January 7, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, October 5, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 3, 2019ASSIGNED TO EXAMINER
Friday, August 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 19, 2019NEW APPLICATION ENTERED

Related Keywords

myquista associated symptoms menopause women disorders hormonal vasomotor severe treatment preparations